Top Markets
Coin of the day
BioInvent International AB (publ) BioInvent International AB (publ)

BioInvent International AB (publ)

BINV
株式のランク #19120
BioInvent International AB (publ) is a clinical-stage Swedish company dedicated... BioInvent International AB (publ) is a clinical-stage Swedish company dedicated to discovering, researching, and developing immunomodulatory antibodies for global cancer treatment, with reach across Sweden, Europe, the United States, and Japan. Its most advanced therapeutic candidate, BI-1206, targets non-Hodgkin lymphoma and various solid tumors. The company's diverse pipeline also features developments aimed at tumor-associated myeloid cells and cancer-associated regulatory T cells, which play a role in modulating the immune system, alongside BT-001 for solid tumors. Furthermore, BioInvent is progressing BI-1808 and BI-1910, a pair of anti-TNFR2 antibodies, designed to combat solid tumors and cutaneous T-cell lymphoma. Strategic collaborations are integral to its operations; these include a partnership with Pfizer Inc. for antibody development against tumor-associated myeloid cells, a co-development effort with Transgene involving multi-functional oncolytic viruses for solid tumors, and an agreement with Merck for the clinical advancement and supply of BI-1808. Established in 1996, BioInvent is based in Lund, Sweden.
株価
$2.65
時価総額
$174.19M
変化(1日)
-2.47%
変化(1年)
-23.88%
SE
取引 BioInvent International AB (publ) (BINV)

カテゴリー

BioInvent International AB (publ)(BINV)の株価履歴
終値の最高値: $2.67 (2026-08-01)

終値の最安値: $85.60 (2001-06-01)
BioInvent International AB (publ) の株価履歴(2001 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -5.41%
2025 -17.47%
2024 117.26%
2023 -47.80%
2022 -36.40%
2021 -5.87%
2020 76.83%
2019 -42.16%
2018 -14.67%
2017 -0.37%
2016 -38.44%
2015 41.60%
2014 -32.92%
2013 14.96%
2012 -78.97%
2011 -41.46%
2010 4.40%
2009 96.44%
2008 -30.58%
2007 116.26%
2006 -0.99%
2005 8.47%
2004 -15.33%
2003 0.92%
2002 -59.80%
2001 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$121.62 -12.98%
AU
$770.45 7.08%
CH